Drug intelligence / Profile preview

ProbioSEB CSC3

Development stage
Preclinical
Lead developer
Specialty Enzymes & Probiotics
Modality
Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

ProbioSEB CSC3 is a synbiotic dietary supplement developed and manufactured by Specialty Enzymes & Probiotics. It is a shelf-stable blend consisting of three specific, spore-forming Bacillus species: *Bacillus coagulans* LBSC (SEBiotic), *Bacillus subtilis* PLSSC (SEBtilis), and *Bacillus clausii* 088AE (SEBclausii), combined with the prebiotic fructooligosaccharide (FOS). [10, 12, 14] The modality is a biologic probiotic complex that works by supporting the balance of the gut microbiome and modulating immune function, rather than targeting a specific molecular pathway like traditional drugs. [13] The spore-forming nature of the bacteria protects them through the acidic environment of the stomach, allowing them to colonize the intestines where they support homeostasis. [8] Clinical studies have evaluated ProbioSEB CSC3 for its role in managing symptoms related to upper respiratory tract infections, COVID-19, and post-COVID-19 fatigue, often in combination with an enzyme complex called ImmunoSEB. [2, 9] It is also marketed for supporting metabolic health, weight management, and for individuals taking GLP-1 agonists. [3]

Brand names
Biome UltraProbioSEB CSC3

Beyond the preview

Go deeper on ProbioSEB CSC3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProbioSEB CSC3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call